We are live on ! Find out more
FLNA

Filana Therapeutics

128 hedge funds and large institutions have $456M invested in Filana Therapeutics in 2021 Q1 according to their latest regulatory filings, with 60 funds opening new positions, 34 increasing their positions, 29 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

590% more capital invested

Capital invested by funds: $66.1M → $456M (+$390M)

445% more first-time investments, than exits

New positions opened: 60 | Existing positions closed: 11

62% more funds holding

Funds holding: 79128 (+49)

61% more call options, than puts

Call options by funds: $83.5M | Put options by funds: $51.8M

17% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 29

2.13% less ownership

Funds ownership: 28.79%26.66% (-2.1%)

Holders
128
Holders Change
+49
Holders Change %
+62.03%
% of All Funds
2.25%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
60
Increased
34
Reduced
29
Closed
11
Calls
$83.5M
Puts
$51.8M
Net Calls
+$31.7M
Net Calls Change
+$32.9M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$108M +$17.1M +434,153 +22%
Vanguard Group
2
Vanguard Group
Pennsylvania
$79.7M +$7.49M +190,315 +12%
State Street
3
State Street
Massachusetts
$30.9M +$9.35M +237,758 +53%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$25.2M +$4.08M +103,857 +23%
BL
5
Bleichroeder LP
New York
$22.5M +$8.48M +215,686 +76%
Group One Trading
6
Group One Trading
Illinois
$18.9M +$14.1M +358,594 +580%
Susquehanna International Group
7
Susquehanna International Group
Pennsylvania
$16.5M +$478K +12,142 +3%
Northern Trust
8
Northern Trust
Illinois
$15.3M -$342K -8,697 -2%
MWNA
9
Marshall Wace North America
New York
$12.7M +$11.1M +282,793 New
Citadel Advisors
10
Citadel Advisors
Florida
$11.1M +$7.17M +182,351 +279%
Millennium Management
11
Millennium Management
New York
$10.3M +$9.01M +228,976 New
Morgan Stanley
12
Morgan Stanley
New York
$10M +$6.77M +172,250 +337%
Marshall Wace
13
Marshall Wace
United Kingdom
$8.81M -$8.33M -211,864 -52%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$6.59M -$827K -21,016 -13%
Charles Schwab
15
Charles Schwab
California
$3.73M +$230K +5,853 +8%
Jane Street
16
Jane Street
New York
$3.27M +$648K +16,482 +29%
California Public Employees Retirement System
17
California Public Employees Retirement System
California
$2.97M
EI
18
EAM Investors
California
$2.73M +$2.39M +60,831 New
Osaic Holdings
19
Osaic Holdings
Arizona
$2.65M +$1.75M +44,615 +313%
SC
20
Saturna Capital
Washington
$2.48M +$1.38M +35,100 +176%
Stifel Financial
21
Stifel Financial
Missouri
$2.47M +$2.16M +54,878 New
Squarepoint
22
Squarepoint
New York
$2.33M -$1.85M -46,960 -48%
KPWS
23
Kestra Private Wealth Services
Texas
$2.26M +$1.97M +50,200 New
California State Teachers Retirement System (CalSTRS)
24
California State Teachers Retirement System (CalSTRS)
California
$2.22M -$5.86K -149 -0.3%
Baird Financial Group
25
Baird Financial Group
Wisconsin
$2.2M +$1.92M +48,879 New

FLNA Hedge Fund Activity: Q1 2021 in Review

128 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q1 2021, worth a combined $456M — up 590% from $66.1M a quarter earlier.

Buyers outnumbered sellers: 60 funds opened new FLNA positions and 11 closed out — a net gain of 49 holders — while 34 added to existing stakes and 29 trimmed.

The largest buyer was BlackRock, adding an estimated $17.1M. The largest seller was Marshall Wace, cutting an estimated $8.33M.

  • 128 institutional investors held Filana Therapeutics (FLNA) as of Q1 2021, up from 79 in Q4 2020.
  • Funds reported $456M of Filana Therapeutics stock for Q1 2021, up 590% quarter-over-quarter.
  • 60 funds opened new Filana Therapeutics positions in Q1 2021 and 11 closed out, a net change of +49 holders.
  • The largest Filana Therapeutics buyer in Q1 2021 was BlackRock, an estimated $17.1M added.
  • The largest Filana Therapeutics seller in Q1 2021 was Marshall Wace, an estimated $8.33M sold.

Based on aggregated 13F filings for Q1 2021.